{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:09:55Z","timestamp":1792706995700,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtho.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T03:02:13Z","timestamp":1704510133000},"page":"866-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregnancy"],"prefix":"10.1016","volume":"19","author":[{"given":"Emily","family":"Simons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ross","family":"Camidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2024.01.003_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/07357907.2017.1295461","article-title":"Lung cancer in never-smoking women: a sub-analysis of the Spanish female-specific database WORLD07","volume":"35","author":"Vinolas","year":"2017","journal-title":"Cancer Investig"},{"key":"10.1016\/j.jtho.2024.01.003_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40880-017-0187-6","article-title":"Proportion and clinical features of never-smokers with non-small cell lung cancer","volume":"36","author":"Cho","year":"2017","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib3","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.cllc.2022.11.003","article-title":"Pregnancy and pathways to motherhood in oncogene-driven lung cancer: a single institution experience","volume":"24","author":"Simons","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(16)31473-8","article-title":"New and emerging targeted treatments in advanced non-small-cell lung cancer","volume":"388","author":"Hirsch","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2024.01.003_bib5","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/cancers13092172","article-title":"Genomic characterization of concurrent alterations in non-small cell lung cancer (NSCLC) harboring actionable mutations","volume":"13","author":"Passaro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2024.01.003_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lungcan.2013.09.002","article-title":"Lung cancer in pregnancy: report of nine cases from an international collaborative study","volume":"82","author":"Boussios","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.lungcan.2009.10.006","article-title":"Lung cancer in the pregnant woman: to treat or not to treat, that is the question","volume":"67","author":"Azim","year":"2010","journal-title":"Lung Cancer"},{"issue":"suppl 6","key":"10.1016\/j.jtho.2024.01.003_bib8","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.jtho.2024.01.003_bib9","first-page":"i","article-title":"NTP monograph: developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy","year":"2013","journal-title":"NTP Monogr"},{"key":"10.1016\/j.jtho.2024.01.003_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-020-0862-7","article-title":"Pregnancy and cancer: the INCIP project","volume":"22","author":"Maggen","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jtho.2024.01.003_bib11","first-page":"295","article-title":"Epidermal growth factor receptor and human fetoplacental development","volume":"7","author":"Evain-Brion","year":"1994","journal-title":"J\u00a0Pediatr Endocrinol"},{"key":"10.1016\/j.jtho.2024.01.003_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111718","article-title":"Defining pathological activities of ALK in neuroblastoma, a neural crest-derived cancer","volume":"22","author":"Wulf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtho.2024.01.003_bib13","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/en.2014-1341","article-title":"ROS1 signaling regulates epithelial differentiation in the epididymis","volume":"155","author":"Jun","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jtho.2024.01.003_bib14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/humu.22688","article-title":"Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart disease","volume":"35","author":"Werner","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtho.2024.01.003_bib15","series-title":"Tagrisso (osimertinib) [package insert]","year":"2020"},{"key":"10.1016\/j.jtho.2024.01.003_bib16","series-title":"Tarceva (erlotinib) [package insert]","year":"2010"},{"key":"10.1016\/j.jtho.2024.01.003_bib17","series-title":"Gilotrif (afatinib) [package insert]","year":"2018"},{"key":"10.1016\/j.jtho.2024.01.003_bib18","series-title":"Iressa (gefitinib) [package insert]","year":"2018"},{"key":"10.1016\/j.jtho.2024.01.003_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/annonc\/mdv172","article-title":"Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model","volume":"26","author":"Jovelet","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2024.01.003_bib30","series-title":"Alecensa (alectinib) [package insert]","year":"2015"},{"key":"10.1016\/j.jtho.2024.01.003_bib29","series-title":"Rybrevant (amivantamab-vmjw) [package insert]","year":"2021"},{"key":"10.1016\/j.jtho.2024.01.003_bib25","series-title":"Alunbrig (brigatinib) [package insert]","year":"2017"},{"key":"10.1016\/j.jtho.2024.01.003_bib22","series-title":"Zykadia (ceritinib) [package insert]","year":"2019"},{"key":"10.1016\/j.jtho.2024.01.003_bib23","series-title":"Xalkori (crizotinib) [package insert]","year":"2017"},{"key":"10.1016\/j.jtho.2024.01.003_bib28","series-title":"Vizimpro (dacomitinib) [package insert]","year":"2018"},{"key":"10.1016\/j.jtho.2024.01.003_bib24","series-title":"Rozlytrek (entrectinib) [package insert]","year":"2019"},{"key":"10.1016\/j.jtho.2024.01.003_bib26","series-title":"Lorbrena (lorlatinib) [package insert]","year":"2021"},{"key":"10.1016\/j.jtho.2024.01.003_bib27","series-title":"Exkivity (mobocertinib) [package insert]","year":"2021"},{"key":"10.1016\/j.jtho.2024.01.003_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lungcan.2021.09.001","article-title":"Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma","volume":"161","author":"Boudy","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfx063","article-title":"Placental disposition and effects of crizotinib: an ex\u00a0vivo study in the isolated dual-side perfused human cotyledon","volume":"157","author":"Eliesen","year":"2017","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jtho.2024.01.003_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2020.151221","article-title":"Drugs in pregnancy: pharmacologic and physiologic changes that affect clinical care","volume":"44","author":"Pinheiro","year":"2020","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jtho.2024.01.003_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jtho.2021.02.005","article-title":"First case report of pregnancy on alectinib in a woman with metastatic ALK-rearranged lung cancer: a case report","volume":"16","author":"Scarfone","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.01.003_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.lungcan.2012.03.026","article-title":"Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma","volume":"77","author":"Rivas","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lungcan.2011.08.008","article-title":"Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure","volume":"74","author":"Lee","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.lungcan.2014.06.003","article-title":"Efficacy and safety of gefitinib during pregnancy: case report and literature review","volume":"85","author":"Gil","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamaoncol.2015.1300","article-title":"Successful treatment of non-small cell lung cancer with erlotinib throughout pregnancy","volume":"1","author":"Ji","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtho.2024.01.003_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pulmoe.2018.03.007","article-title":"Lung cancer in pregnancy - report of a case treated with crizotinib","volume":"24","author":"Padrao","year":"2018","journal-title":"Pulmonology"},{"key":"10.1016\/j.jtho.2024.01.003_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/0284186X.2018.1497302","article-title":"Antineoplastic treatment with crizotinib during pregnancy: a case report","volume":"58","author":"Jensen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtho.2024.01.003_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2007.10.025","article-title":"Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy","volume":"60","author":"Zambelli","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.01.003_bib40","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/j.jtho.2019.03.016","article-title":"Is ALK inhibitor a contraindication for subsequent IVF pregnancy?","volume":"14","author":"Gillis","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.01.003_bib41","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.fertnstert.2016.08.011","article-title":"Ovarian stimulation in young adult cancer survivors on targeted cancer therapies","volume":"106","author":"Su","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jtho.2024.01.003_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ol.2022.13640","article-title":"A pregnant patient with ALK-positive non-small cell lung cancer treated with alectinib: A case report and review of the literature","volume":"25","author":"De Smedt","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2024.01.003_bib42","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jtho.2016.05.031","article-title":"Clinicopathologic features of NSCLC diagnosed during pregnancy or the peripartum period in the era of molecular genotyping","volume":"11","author":"Dagogo-Jack","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.01.003_bib43","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.21037\/jtd-21-234","article-title":"Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer","volume":"13","author":"Yang","year":"2021","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2024.01.003_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.breast.2022.04.002","article-title":"Meeting the proposal for service improvement for pregnant women with cancer","volume":"64","author":"Cardonick","year":"2022","journal-title":"Breast"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086424000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086424000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T01:50:22Z","timestamp":1748742622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086424000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1556086424000236"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2024.01.003","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}